Because conditions such as chronic fatigue, Lyme, mold-related illness, and Long Covid consistently involve the same core biological domains (the Big 6), it is rarely necessary to test every possible variable before taking structured action.

The Big 6 framework ensures that all major root driver categories are addressed systematically — rather than waiting for laboratory confirmation of each individual factor. In complex chronic illness, waiting for perfect data often delays meaningful progress.

In practice, I prioritize testing only where it meaningfully alters strategy. This most commonly includes environmental mold assessment and evaluation for sleep-disordered breathing, as these two factors are frequently overlooked yet highly impactful drivers.

This does not mean I am opposed to laboratory testing. Testing can be valuable when it provides actionable information or changes clinical direction. Additional labs may be included when indicated by the case.

By working through all core domains in a structured manner — rather than chasing isolated findings — we reduce blind spots and avoid fragmented care. This approach typically leads to more consistent outcomes while reducing unnecessary financial burden, since we are not dependent on extensive laboratory panels to guide every step.